Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

about

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

Item

http://www.wikidata.org/entity/Q55364385

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

@en

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

@nl

type

Item

label

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

@en

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

@nl

prefLabel

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

@en

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

@nl

P1476

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

@en

P2093

A G Dalgleish

http://www.w3.org/2001/XMLSchema#string

A M Gravett

http://www.w3.org/2001/XMLSchema#string

J Copier

http://www.w3.org/2001/XMLSchema#string

N Trautwein

http://www.w3.org/2001/XMLSchema#string

S Stevanović

http://www.w3.org/2001/XMLSchema#string

P2860

26S proteasomes and immunoproteasomes produce mainly N-extended versions of an antigenic peptide.

The urgent need to recover MHC class I in cancers for effective immunotherapy

HLA peptide length preferences control CD8+ T cell responses

The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing.

Chemotherapeutics and radiation stimulate MHC class I expression through elevated interferon-beta signaling in breast cancer cells

Induction of protective antitumor immunity through attenuation of ERAAP function

Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products.

Toward a definition of self: proteomic evaluation of the class I peptide repertoire.

A study of T cell tolerance to the tumor-associated antigen MDM2: cytokines can restore antigen responsiveness, but not high avidity T cell function

Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses

P304

e1438107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2018.1438107

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29930882

http://www.w3.org/2001/XMLSchema#string

P932

5990974

http://www.w3.org/2001/XMLSchema#string